Bioinformatics Market Grows Driven by AI and Multi-Omics, Reaching $46.9 Billion by 2035
The global bioinformatics market reached $16.34 billion in 2025 and is projected to reach $46.92 billion by 2035, growing at a 12.8% CAGR. AI and multi-omics integration are key drivers.
Leander, Texas – The bioinformatics market is projected to expand from $16.34 billion in 2025 to $46.92 billion by 2035, exhibiting a compound annual growth rate of 12.8%. DataM Intelligence reports that the integration of Artificial Intelligence (AI) and multi-omics data is accelerating adoption and driving advancements in healthcare and drug discovery.
The market's growth is propelled by several factors, including the increasing adoption of genomics and personalized medicine. Additionally, the rising use of AI and machine learning, coupled with the expansion of cloud computing and big data analytics, are significant contributors. A growing demand for nucleic acid and protein sequencing also fuels the need for sophisticated bioinformatics solutions.
North America currently leads the bioinformatics market, supported by its advanced healthcare systems, substantial R&D investments, and strong biotechnology funding. The region benefits from a close integration between research and commercialization, where pharmaceutical companies leverage bioinformatics for target identification and drug development.
The Asia Pacific region is experiencing the fastest growth. This expansion is attributed to growing genomics programs, increased pharmaceutical and biotechnology R&D, and improving digital healthcare infrastructure. Key countries like China, India, Japan, and South Korea are becoming prominent in clinical genomics and AI-assisted research.
A notable challenge highlighted is the shortage of skilled professionals in bioinformatics, requiring expertise in both biology and computational science. This scarcity could potentially impede the implementation of new tools and the pace of analytical method development.